News • Endocrinology

Predicting the outcome for newborns with congenital hyperinsulinism

Babies born with congenital hyperinsulinism (CHI) are at risk of suffering from permanent brain damage and life-long disability.

newborn baby feet
Source: Unsplash/Ignacio Campo

Yet some will go on to suffer more severely than others as a result of their disease profile, report the researchers in an article published in Frontiers in Endocrinology. The research team have found that it is possible to predict when and how the disease may affect the child in the long-term. “One of the problems facing clinicians is that it is really difficult to predict which babies will have problems after surgical treatment. Our new data give some important clues that will help clinicians to know how much extra care each baby is likely to need”, explains Dr Karen Cosgrove, a member of the research team from The University of Manchester. Although generally rare, affecting just 1 in 50,000 children in the UK, CHI can be as common as cystic fibrosis (1 in 2,500) in children of European Jewish descent or when born into communities where cousins marry.

Although the impact of these findings is limited to centres with surgical resources, for those centres the data is immediately applicable and translatable clinically

Mark Dunne

Up until now, scientists have understood that there are two main subtypes of the disease - known as diffuse and focal. Diffuse CHI affects the entire pancreas, whilst focal CHI affects just one area of the organ, forming a focal lesion. The team from Manchester now understand that focal CHI can be further categorised into two types- spreading focal lesions and isolated focal lesions. Spreading focal lesions are generally larger and spread outwards into areas of healthy cells. Isolated focal lesions, on the other hand, have a capsule around them which keeps the diseased cells separate from healthy cells.

The research team investigated the cases of 25 infants with focal CHI to see how the two types of lesions influenced their long-term outcomes. They found that babies with spreading focal lesions suffered more severely from the disease and were diagnosed earlier. These infants were more likely to suffer brain damage which permanently affected their development, learning and behaviour. In contrast, in infants with isolated lesions, the disease was diagnosed later and surgery to remove the lesion was less complicated.

These new data help to explain why new-born babies diagnosed with the same disease may go on to have very different outcomes and could influence the way clinicians choose to manage each new case of CHI. “Although the impact of these findings is limited to centres with surgical resources, for those centres the data is immediately applicable and translatable clinically” explains Professor Mark Dunne from The University of Manchester and lead author on the study.


Source: University of Manchester

02.04.2019

More on the subject:
Read all latest stories

Related articles

Photo

News • Lack of photos in published studies

The unseen faces of psiorasis in science

Scientific articles about psiorasis suffer from a shortage of actual patient images, according to a new study. This makes it hard for patients to grasp the condition, the authors argue.

Photo

News • Overcoming a common mental health belief

Suppressing negative thoughts might not be so bad after all

The commonly-held belief that attempting to suppress negative thoughts is bad for our mental health could be wrong, a new study from scientists at the University of Cambridge suggests.

Photo

News • Women's health

Cadmium levels in urine linked to endometriosis

Women with a history of endometriosis had higher concentrations of cadmium in their urine compared to those without that diagnosis, a new study finds, linking the toxic metal to the condition.

Related products

Low DNA Binding Micro Tubes

Research Use Only

Sarstedt · Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
teamplay Images

Portal Solutions

Siemens Healthineers · teamplay Images

Siemens Healthineers AG
Subscribe to Newsletter